guanidine has been researched along with pyridostigmine bromide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riggs, JE | 1 |
Claussen, GC; Head, TC; Kim, DS; Oh, SJ | 1 |
Claussen, GC; Kim, DS; Kwon, KH; Mussell, H; Oh, SJ; Tseng, A | 1 |
Titulaer, MJ; van Gerven, J; Verschuuren, JJ; Willems, LN; Wirtz, PW | 1 |
Maddison, P | 1 |
3 review(s) available for guanidine and pyridostigmine bromide
Article | Year |
---|---|
Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
Topics: 4-Aminopyridine; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Ambenonium Chloride; Aminopyridines; Calcium; Cholinesterase Inhibitors; Cyclic AMP; Edrophonium; Ephedrine; Germine Acetates; Guanidine; Guanidines; Humans; Myasthenia Gravis; Neostigmine; Neuromuscular Depolarizing Agents; Neuromuscular Junction; Potassium; Pyridostigmine Bromide; Synapses; Synaptic Transmission | 1982 |
Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Antineoplastic Agents; Carcinoma, Small Cell; Cholinesterase Inhibitors; Cisplatin; Etoposide; Guanidine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Parasympathomimetics; Plasmapheresis; Potassium Channel Blockers; Prednisolone; Pyridostigmine Bromide; Randomized Controlled Trials as Topic | 2006 |
Treatment in Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Amifampridine; Antineoplastic Agents; Guanidine; Humans; Immunoglobulins, Intravenous; Lambert-Eaton Myasthenic Syndrome; Placebos; Potassium Channel Blockers; Pyridostigmine Bromide; Randomized Controlled Trials as Topic | 2012 |
1 trial(s) available for guanidine and pyridostigmine bromide
Article | Year |
---|---|
Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome.
Topics: Adult; Aged; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophysiology; Female; Guanidine; Guanidines; Humans; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Neoplasms; Pyridostigmine Bromide; Time Factors; Treatment Outcome | 1997 |
1 other study(ies) available for guanidine and pyridostigmine bromide
Article | Year |
---|---|
Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Adult; Aged; Amifampridine; Carcinoma, Small Cell; Female; Guanidine; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Parasympathomimetics; Potassium Channel Blockers; Pyridostigmine Bromide; Retrospective Studies; Thyroid Neoplasms | 1998 |